08 Sep 2020
Gilead, AstraZeneca and Pfizer likely to win the COVID-19 treatment development race
By Staff Writer
More than 1 200 therapeutics and vaccines have entered the research and development (R&D) pipeline since January 2020 and this number grows every week says data and analytics company GlobalData. According to GlobalData’s Clinical and Commercial Analyser tool, which rates the most promising and high-profile assets on a range of clinical and commercial attributes, remdesivir...